STEVENS CAPITAL MANAGEMENT LP - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$35,000
-58.8%
15,766
-63.8%
0.00%
-66.7%
Q1 2015$85,000
-49.1%
43,591
-30.9%
0.00%
-50.0%
Q4 2014$167,000
-30.7%
63,123
-21.0%
0.01%
-14.3%
Q3 2014$241,000
-31.3%
79,927
-7.0%
0.01%
-22.2%
Q2 2014$351,000
+663.0%
85,937
+703.0%
0.01%
+800.0%
Q1 2014$46,000
-47.7%
10,702
-36.3%
0.00%
-66.7%
Q4 2013$88,000
+31.3%
16,802
+58.5%
0.00%
+50.0%
Q3 2013$67,00010,6010.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2013
NameSharesValueWeighting ↓
CAXTON CORP 28,639,349$123,436,00094.21%
Verity Asset Management, Inc. 103,021$456,0000.47%
NBW CAPITAL LLC 242,153$1,044,0000.27%
Old West Investment Management, LLC 69,997$301,0000.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 196,639$848,0000.12%
SOPHROSYNE CAPITAL LLC 25,700$111,0000.10%
Cutler Capital Management, LLC 45,000$194,0000.08%
Rotella Capital Management, Inc. 11,700$50,0000.06%
STONERIDGE INVESTMENT PARTNERS LLC 66,397$286,0000.06%
Roundview Capital LLC 21,100$91,0000.04%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders